CyPB, also known as Cyclophilin B, is a peptidyl-prolyl cis-trans isomerase (PPIase) enzyme encoded by the PPIB gene. It belongs to the cyclophilin family of proteins, which are widely distributed and highly conserved across species. CyPB is primarily localized in the endoplasmic reticulum (ER) and functions as a molecular chaperone, assisting in the folding and trafficking of newly synthesized proteins. Additionally, CyPB plays a role in protein quality control by facilitating the degradation of misfolded proteins through the ER-associated degradation (ERAD) pathway. Furthermore, CyPB has been implicated in various cellular processes, including cell signaling, immune response, and viral replication, highlighting its diverse functions beyond protein folding.
The activation of CyPB involves several intricate mechanisms that regulate its enzymatic activity and cellular functions. One key aspect of CyPB activation is its interaction with its substrate proteins, particularly those containing proline residues in their polypeptide chains. CyPB catalyzes the cis-trans isomerization of peptide bonds involving proline residues, thereby facilitating protein folding and conformational changes essential for proper protein function. Moreover, post-translational modifications such as phosphorylation, acetylation, and glycosylation may modulate CyPB activity and subcellular localization, influencing its ability to interact with client proteins and participate in various cellular processes. Additionally, CyPB activity can be regulated by intracellular signaling pathways and protein-protein interactions, allowing for precise control of its function in response to cellular cues and environmental stimuli. Overall, understanding the mechanisms underlying CyPB activation is crucial for elucidating its role in protein homeostasis and cellular physiology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK506, similar to Cyclosporin A, inhibits calcineurin and forms a complex with CyPB. This interaction influences immune response regulation, providing an indirect mechanism for CyPB activation through modulation of the calcineurin-CyPB complex. | ||||||
Debio 0932 | 1061318-81-7 | sc-507516 | 10 mg | $280.00 | ||
Debio 0932 is a cyclophilin inhibitor that interacts with CyPB. By binding to CyPB, it may influence cellular processes in which CyPB is involved. The inhibition of CyPB by Debio 0932 can potentially lead to altered cellular responses and contribute to CyPB activation. | ||||||